These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33519787)

  • 41. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex.
    Tomioka H
    Curr Drug Discov Technol; 2004 Dec; 1(4):255-68. PubMed ID: 16472242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis.
    Shuto H; Komiya K; Goto A; Kan T; Honjo K; Uchida S; Takikawa S; Yoshimatsu T; Yamasue M; Hiramatsu K; Kadota JI
    PLoS One; 2020; 15(7):e0235797. PubMed ID: 32645105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
    Mascellino MT; Iona E; Fattorini L; De Gregoris P; Hu CQ; Santoro C; Orefici G
    J Chemother; 1991 Dec; 3(6):357-62. PubMed ID: 1840274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimum inhibitory concentrations of azithromycin in clinical isolates of
    Uwamino Y; Aoki W; Inose R; Kamoshita Y; Mikita K; Namkoong H; Nishimura T; Matsushita H; Hasegawa N
    Microbiol Spectr; 2024 Jun; 12(6):e0021824. PubMed ID: 38687080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
    Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
    J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs.
    Tomioka H; Sato K; Saito H; Yamada Y
    Microbiol Immunol; 1989; 33(6):509-14. PubMed ID: 2770562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
    Fattorini L; Hu CQ; Jin SH; Santoro C; Tsang AY; Mascellino MT; Mandler F; Orefici G
    Zentralbl Bakteriol; 1992 Apr; 276(4):512-20. PubMed ID: 1611208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
    Yajko DM; Nassos PS; Sanders CA; Hadley WK
    Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.
    Peters K; Leitzke S; Diederichs JE; Borner K; Hahn H; Müller RH; Ehlers S
    J Antimicrob Chemother; 2000 Jan; 45(1):77-83. PubMed ID: 10629016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model.
    Cha SB; Jeon BY; Kim WS; Kim JS; Kim HM; Kwon KW; Cho SN; Shin SJ; Koh WJ
    PLoS One; 2015; 10(9):e0139251. PubMed ID: 26406237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
    Reddy MV; Srinivasan S; Gangadharam PR
    Tuber Lung Dis; 1994 Jun; 75(3):208-12. PubMed ID: 7919314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
    Fournier S; Burguière AM; Flahault A; Vincent V; Treilhou MP; Eliaszewicz M
    Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):16-22. PubMed ID: 10192709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of nontuberculous mycobacterial infections in pediatric patients.
    Levin RH; Bolinger AM
    Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
    Sano C; Tatano Y; Shimizu T; Yamabe S; Sato K; Tomioka H
    Int J Antimicrob Agents; 2011 Apr; 37(4):296-301. PubMed ID: 21353489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice.
    Saito H; Sato K
    Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.